Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness

Hyperemia Clinical Trial

Official title:
A Single-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% Used Four Times Daily in a Population of Adult and Geriatric Subjects With Ocular Redness

Status Completed

Clinical Trial Summary

To compare the efficacy and safety of brimonidine tartrate ophthalmic solution 0.025% with its vehicle for the treatment of ocular redness in a population of adult and geriatric participants with ocular redness.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01959230
Study type	Interventional
Source	Bausch & Lomb Incorporated
Contact
Status	Completed
Phase	Phase 3
Start date	November 7, 2013
Completion date	December 20, 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02136589` - Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes	Phase 4
Recruiting	`NCT05706181` - Heat Therapy, Functional Capacity, and Vascular Health in Older Adults	Phase 1/Phase 2
Completed	`NCT01642147` - Cerebral Blood Perfusion Changes After General Anesthesia for Craniotomy	N/A
Withdrawn	`NCT04132648` - Curcumin and Exercise in Chronic Kidney Disease	Phase 2
Recruiting	`NCT02183779` - PORH and Response to Cold in Raynaud's Phenomenon.	N/A
Completed	`NCT01959243` - Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants	Phase 3
Completed	`NCT02039765` - Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.	Phase 1
Completed	`NCT00268554` - Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole	N/A